chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for Covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.  No Medical History information was reported.  On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced COVID-19 (tested positive for Covid). At the time of the report, COVID-19 (tested positive for Covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis contact
Clinical narrative: Poison oak infection; This spontaneous case was reported by a consumer and describes the occurrence of POISON OAK RASH (Poison oak infection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bronchitis.  Previously administered products included for an unreported indication: TRIAMCINOLONE ACETONIDE (for poison oak) on 15-Mar-2021.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced POISONING (Poison oak infection) (seriousness criterion medically significant) and DRUG INEFFECTIVE (Potentially reduced efficacy due to treatment). At the time of the report, POISONING (Poison oak infection) and DRUG INEFFECTIVE (Potentially reduced efficacy due to treatment) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication not reported.  Treatment medication not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Lymphadenopathy, Pharyngeal swelling, Pyrexia, Seasonal allergy
Clinical narrative: swollen throat that hurts when she swallows; having normal seasonal allergy symptoms; feels like symptoms are getting worse everyday; swollen lymph nodes in both sides of nec; lowgrade fever; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (swollen throat that hurts when she swallows), SEASONAL ALLERGY (having normal seasonal allergy symptoms), CONDITION AGGRAVATED (feels like symptoms are getting worse everyday), LYMPHADENOPATHY (swollen lymph nodes in both sides of nec) and PYREXIA (lowgrade fever) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included PROPRANOLOL, VALACICLOVIR HYDROCHLORIDE (VALTREX), VITAMIN B12 [VITAMIN B12 NOS] and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PHARYNGEAL SWELLING (swollen throat that hurts when she swallows), SEASONAL ALLERGY (having normal seasonal allergy symptoms), CONDITION AGGRAVATED (feels like symptoms are getting worse everyday), LYMPHADENOPATHY (swollen lymph nodes in both sides of nec) and PYREXIA (lowgrade fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, PHARYNGEAL SWELLING (swollen throat that hurts when she swallows), SEASONAL ALLERGY (having normal seasonal allergy symptoms), CONDITION AGGRAVATED (feels like symptoms are getting worse everyday), LYMPHADENOPATHY (swollen lymph nodes in both sides of nec) and PYREXIA (lowgrade fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Myalgia, Pain
Clinical narrative: Diarrhea; General pain; Chills; Aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN (General pain), CHILLS (Chills) and MYALGIA (Aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN (General pain), CHILLS (Chills) and MYALGIA (Aches). On 05-Apr-2021, DIARRHOEA (Diarrhea), PAIN (General pain), CHILLS (Chills) and MYALGIA (Aches) had resolved. Not Provided          No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable       This case was linked to MOD21-070310 (E2B Linked Report).; Sender's Comments:  MOD21-070310:Wife's Case
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Vaccination site movement impairment
Clinical narrative: sore arm; very very tired; Was hardly able to lift it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE MOVEMENT IMPAIRMENT (Was hardly able to lift it) and FATIGUE (very very tired) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), VACCINATION SITE MOVEMENT IMPAIRMENT (Was hardly able to lift it) and FATIGUE (very very tired). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE MOVEMENT IMPAIRMENT (Was hardly able to lift it) and FATIGUE (very very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Intentional product use issue
Clinical narrative: She didn't get the 2nd dose on time/second dose delayed beyond 36 days; She was ill; This spontaneous case was reported by a nurse and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (She didn't get the 2nd dose on time/second dose delayed beyond 36 days) and ILLNESS (She was ill) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (She didn't get the 2nd dose on time/second dose delayed beyond 36 days) and ILLNESS (She was ill). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (She didn't get the 2nd dose on time/second dose delayed beyond 36 days) and ILLNESS (She was ill) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Epistaxis, Fatigue
Clinical narrative: nose-bleeds; was experiencing chills; has been tired; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose-bleeds), CHILLS (was experiencing chills) and FATIGUE (has been tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced EPISTAXIS (nose-bleeds), CHILLS (was experiencing chills) and FATIGUE (has been tired). At the time of the report, EPISTAXIS (nose-bleeds), CHILLS (was experiencing chills) and FATIGUE (has been tired) outcome was unknown. Not Provided          No relevant concomitant medications reported.  No treatment information was provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old patient got vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient got vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient got vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old patient got vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were  reported.  No treatment information was provided.   This case was linked to MOD-2021-068440 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28-jun-2021 - Contact details and patient race were updated; Sender's Comments:  MOD-2021-068440:Same Reporter,Different patient identifier
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration interrupted
Clinical narrative: Missed the 42 day window/ never received the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (Missed the 42 day window/ never received the second dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (Missed the 42 day window/ never received the second dose). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (Missed the 42 day window/ never received the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided. No treatment medications were provided.  This report refers to a case of Product administration interrupted for mRNA-1273, lot # unknown, with no associated AEs.; Sender's Comments: This report refers to a case of Product administration interrupted for mRNA-1273, lot # unknown, with no associated AEs.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: Took the first dose of the Moderna COVID-19 vaccine on 20Jan2021; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and PRODUCT DOSE OMISSION ISSUE (Took the first dose of the Moderna COVID-19 vaccine on 20Jan2021) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 27-Jan-2021. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Took the first dose of the Moderna COVID-19 vaccine on 20Jan2021). At the time of the report, COVID-19 (COVID-19) had resolved and PRODUCT DOSE OMISSION ISSUE (Took the first dose of the Moderna COVID-19 vaccine on 20Jan2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product included Lilly COVID-19 antibody infusion.  No treatment reported.   This case was linked to MOD-2021-068432 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy) in a 33-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Live, full-term birth) on 15-Nov-2015 and Pregnancy (Live, full-term birth) on 14-Oct-2017.    On 06-Apr-2021 at 10:39 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Aug-2020 and the estimated date of delivery was 30-Apr-2021. On 06-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fifth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Full-term. For neonate 1, The outcome was reported as Term Birth w/o Complications. No negative effect has been noted with my recently born child. The baby was born after the first dose and 4 days before the second dose. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided.  Treatment medications was not provided.   This case was linked to MOD-2021-237236, MOD-2021-237236 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Updated events after second dose.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site discomfort
Clinical narrative: On and off chills that were not severe; Had some discomfort in the site of injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE DISCOMFORT (Had some discomfort in the site of injection) and CHILLS (On and off chills that were not severe) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006(A/B)21A) for COVID-19 vaccination.     The patient's past medical history included Hypertension (High) since an unknown date. Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced CHILLS (On and off chills that were not severe). In March 2021, the patient experienced VACCINATION SITE DISCOMFORT (Had some discomfort in the site of injection). At the time of the report, VACCINATION SITE DISCOMFORT (Had some discomfort in the site of injection) and CHILLS (On and off chills that were not severe) outcome was unknown. Not Provided          Concomitant medication include Rivaroxaban for blood thinner, Thyroid medications for unknown use, antihistamine for unknown use Treatment information was not provided.   This case was linked to MOD-2021-068458 (Patient Link).
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dyspnoea, Hypertension, Oxygen saturation
Clinical narrative: pain at the site of injection; Symptoms have gone from her middle arm to her elbow; has high blood pressure; periodically I need to take a deep breat and i neve had to do that before.; Left arm was red; Left arm was swollen; I was just so achy everywhere that i just did nothing all day, stayed in my chair; achy in different places that comes and goes; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (I was just so achy everywhere that i just did nothing all day, stayed in my chair), ARTHRALGIA (Symptoms have gone from her middle arm to her elbow), HYPERTENSION (has high blood pressure), PAIN (achy in different places that comes and goes) and DYSPNOEA (periodically I need to take a deep breat and i neve had to do that before.) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006 (A / B )) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 08-Mar-2021, the patient experienced CHILLS (chills). On 03-Apr-2021, the patient experienced PAIN (I was just so achy everywhere that i just did nothing all day, stayed in my chair) and PAIN (achy in different places that comes and goes). On 04-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Left arm was red) and VACCINATION SITE SWELLING (Left arm was swollen). On 05-Apr-2021, the patient experienced ARTHRALGIA (Symptoms have gone from her middle arm to her elbow), HYPERTENSION (has high blood pressure) and DYSPNOEA (periodically I need to take a deep breat and i neve had to do that before.). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain at the site of injection). At the time of the report, PAIN (I was just so achy everywhere that i just did nothing all day, stayed in my chair), ARTHRALGIA (Symptoms have gone from her middle arm to her elbow), HYPERTENSION (has high blood pressure), PAIN (achy in different places that comes and goes), DYSPNOEA (periodically I need to take a deep breat and i neve had to do that before.), PAIN IN EXTREMITY (pain at the site of injection), VACCINATION SITE ERYTHEMA (Left arm was red), VACCINATION SITE SWELLING (Left arm was swollen) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 98 (Inconclusive) 98.         Other relevant concomitatnt medications included Thyroid medications and antihistamine (when needed)  Treatment medication were provided as steroid injection  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vaccination site erythema, Vaccination site swelling
Clinical narrative: pain at the site of injection; Symptoms have gone from her middle arm to her elbow; has high blood pressure; periodically I need to take a deep breat and i neve had to do that before.; Left arm was red; Left arm was swollen; I was just so achy everywhere that i just did nothing all day, stayed in my chair; achy in different places that comes and goes; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (I was just so achy everywhere that i just did nothing all day, stayed in my chair), ARTHRALGIA (Symptoms have gone from her middle arm to her elbow), HYPERTENSION (has high blood pressure), PAIN (achy in different places that comes and goes) and DYSPNOEA (periodically I need to take a deep breat and i neve had to do that before.) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006 (A / B )) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 08-Mar-2021, the patient experienced CHILLS (chills). On 03-Apr-2021, the patient experienced PAIN (I was just so achy everywhere that i just did nothing all day, stayed in my chair) and PAIN (achy in different places that comes and goes). On 04-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Left arm was red) and VACCINATION SITE SWELLING (Left arm was swollen). On 05-Apr-2021, the patient experienced ARTHRALGIA (Symptoms have gone from her middle arm to her elbow), HYPERTENSION (has high blood pressure) and DYSPNOEA (periodically I need to take a deep breat and i neve had to do that before.). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain at the site of injection). At the time of the report, PAIN (I was just so achy everywhere that i just did nothing all day, stayed in my chair), ARTHRALGIA (Symptoms have gone from her middle arm to her elbow), HYPERTENSION (has high blood pressure), PAIN (achy in different places that comes and goes), DYSPNOEA (periodically I need to take a deep breat and i neve had to do that before.), PAIN IN EXTREMITY (pain at the site of injection), VACCINATION SITE ERYTHEMA (Left arm was red), VACCINATION SITE SWELLING (Left arm was swollen) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 98 (Inconclusive) 98.         Other relevant concomitatnt medications included Thyroid medications and antihistamine (when needed)  Treatment medication were provided as steroid injection  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, SARS-CoV-2 test, SARS-CoV-2 test negative, Skin discolouration, Swelling
Clinical narrative: swelling on pinky toe; purple pinky toe; negative COVID-19 test; itching on feet; Hives on feet; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on feet), URTICARIA (Hives on feet), SWELLING (swelling on pinky toe), SKIN DISCOLOURATION (purple pinky toe) and SARS-COV-2 TEST NEGATIVE (negative COVID-19 test) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included BUPROPION and ARIPIPRAZOLE for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PRURITUS (itching on feet) and URTICARIA (Hives on feet). On 06-Apr-2021, the patient experienced SARS-COV-2 TEST NEGATIVE (negative COVID-19 test). On an unknown date, the patient experienced SWELLING (swelling on pinky toe) and SKIN DISCOLOURATION (purple pinky toe). On 03-Apr-2021, PRURITUS (itching on feet) and URTICARIA (Hives on feet) had resolved. At the time of the report, SWELLING (swelling on pinky toe), SKIN DISCOLOURATION (purple pinky toe) and SARS-COV-2 TEST NEGATIVE (negative COVID-19 test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, SARS-CoV-2 test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included diphenhydramine.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: swelling on pinky toe; purple pinky toe; negative COVID-19 test; itching on feet; Hives on feet; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on feet), URTICARIA (Hives on feet), SWELLING (swelling on pinky toe), SKIN DISCOLOURATION (purple pinky toe) and SARS-COV-2 TEST NEGATIVE (negative COVID-19 test) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included BUPROPION and ARIPIPRAZOLE for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PRURITUS (itching on feet) and URTICARIA (Hives on feet). On 06-Apr-2021, the patient experienced SARS-COV-2 TEST NEGATIVE (negative COVID-19 test). On an unknown date, the patient experienced SWELLING (swelling on pinky toe) and SKIN DISCOLOURATION (purple pinky toe). On 03-Apr-2021, PRURITUS (itching on feet) and URTICARIA (Hives on feet) had resolved. At the time of the report, SWELLING (swelling on pinky toe), SKIN DISCOLOURATION (purple pinky toe) and SARS-COV-2 TEST NEGATIVE (negative COVID-19 test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, SARS-CoV-2 test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included diphenhydramine.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Inappropriate age at vaccine administration; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included Disabled child (16 year old male with special needs disabled and non-verbal) since an unknown date.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). On 02-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The mother of the consumer said the consumer is disabled and non-verbal, but he appears to be fine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Coordination abnormal, Fatigue, Feeling abnormal
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of feeling abnormal (brain fog), abnormal coordination (lack of coordination), fatigue and chills in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 029A21A) for COVID-19 vaccination. No medical history reported. On Mar 30, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 3, 2021, patient experienced feeling abnormal (brain fog), abnormal coordination (lack of coordination), fatigue and chills). At the time of the report, feeling abnormal (brain fog), abnormal coordination (lack of coordination), fatigue and chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal discomfort, Pruritus, Rash, Urticaria
Clinical narrative: throat starts to close; Itching/pruritus; Cough; hives appeared on sides, arms but not at injection site,; Rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives appeared on sides, arms but not at injection site,), OROPHARYNGEAL DISCOMFORT (throat starts to close), PRURITUS (Itching/pruritus), COUGH (Cough) and RASH (Rash) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011A21A) for COVID-19 vaccination.     The patient's past medical history included Hives (throat starts to close.) on 01-Jan-1980 and Stent insertion NOS. Concurrent medical conditions included Shellfish allergy (shrimp). Concomitant products included NIFEDIPINE and ACETYLSALICYLIC ACID (ASPIRIN LOW) for Anticoagulant therapy, ATORVASTATIN for Cholesterol, VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced RASH (Rash). On 12-Feb-2021, the patient experienced URTICARIA (hives appeared on sides, arms but not at injection site,). On an unknown date, the patient experienced OROPHARYNGEAL DISCOMFORT (throat starts to close), PRURITUS (Itching/pruritus) and COUGH (Cough). The patient was treated with PREDNISONE for Symptomatic treatment, at a dose of 1 mg; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at a dose of 1 dosage form; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Rash, at a dose of 180 mg; EPINEPHRINE for Symptomatic treatment, at a dose of 1 dosage form; TRIAMCINOLONE for Itching, at a dose of 1 dosage form four times; DOXEPIN for Symptomatic treatment, at a dose of 10 mg   2x daily for 5 months and FAMOTIDINE for Symptomatic treatment, at a dose of 40 mg daily for 9 months. At the time of the report, URTICARIA (hives appeared on sides, arms but not at injection site,), PRURITUS (Itching/pruritus), COUGH (Cough) and RASH (Rash) had not resolved and OROPHARYNGEAL DISCOMFORT (throat starts to close) had resolved.            Treatment medications of the patient also included Antihistamines, Oxygen Concomitant medication start date : Nifedipine (??-02-2014), low dose aspirin (??-02-2014), Atorvastatin (??-02-2014), Vitamin C (??-04-2014). treatment medications : Prednisone  10mg 3 tablets daily for 3 days, 2 tablets for 2 days and 1 tablet for 2 days (first time).  20mg, 2 daily for 5 days, 1 tablet daily for 5 days (second time). Stent was put in ??-02-2014   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up was received on (27-MAY-2021) Patient demographics, events, concomitant medications, medical history, treatment medications, vaccination facility details added. Dose details updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Rhinorrhoea
Clinical narrative: Chills; Runny Nose; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and RHINORRHOEA (Runny Nose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced CHILLS (Chills) and RHINORRHOEA (Runny Nose). At the time of the report, CHILLS (Chills) and RHINORRHOEA (Runny Nose) outcome was unknown. Not Provided          No concomitant medication was reported.  The treatment information was unknown.  Action taken with mRNA-1273 in response to the events were not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling of despair
Clinical narrative: Feeling of hopelessness, felt like death was upon her; Immense fatigue; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING OF DESPAIR (Feeling of hopelessness, felt like death was upon her) and FATIGUE (Immense fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Bipolar disorder and Anxiety. Concomitant products included LITHIUM for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING OF DESPAIR (Feeling of hopelessness, felt like death was upon her) and FATIGUE (Immense fatigue). At the time of the report, FEELING OF DESPAIR (Feeling of hopelessness, felt like death was upon her) and FATIGUE (Immense fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient concomitant medication include  Antipsychotic medication.  No treatment drugs were reported
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: bad Headache; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad Headache) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history not reported.).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 26-Feb-2021, the patient experienced HEADACHE (bad Headache) and DIZZINESS (dizziness). At the time of the report, HEADACHE (bad Headache) and DIZZINESS (dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-068476 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068476:Dose 2
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old who received the Moderna COVID-19; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old who received the Moderna COVID-19) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old who received the Moderna COVID-19). On 05-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old who received the Moderna COVID-19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This report refers to a case of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE for mRNA1273 with no associated adverse events.; Sender's Comments: This report refers to a case of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE for mRNA1273 with no associated adverse events.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: Stomach not feeling well, "My stomach is doing back flips", "my stomach medication that I; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach not feeling well, "My stomach is doing back flips", "my stomach medication that I) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach not feeling well, "My stomach is doing back flips", "my stomach medication that I). At the time of the report, ABDOMINAL DISCOMFORT (Stomach not feeling well, "My stomach is doing back flips", "my stomach medication that I) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medication included water pill- 25 mg.  No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Injection site pain; Chills; Body temperature of 101; Fatigue; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Body temperature of 101) and FATIGUE (Fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache). On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Body temperature of 101), FATIGUE (Fatigue) and MYALGIA (Muscle pain). At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Body temperature of 101), FATIGUE (Fatigue) and MYALGIA (Muscle pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment medications was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; Chills; Body temperature of 101; Fatigue; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Body temperature of 101) and FATIGUE (Fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache). On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Body temperature of 101), FATIGUE (Fatigue) and MYALGIA (Muscle pain). At the time of the report, HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), CHILLS (Chills), PYREXIA (Body temperature of 101), FATIGUE (Fatigue) and MYALGIA (Muscle pain) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment medications was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Headache, Pain in extremity
Clinical narrative: arm hurt; shortness of breath; Diarrhea; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), DYSPNOEA (shortness of breath), DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt), DYSPNOEA (shortness of breath), DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (arm hurt), DYSPNOEA (shortness of breath), DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with ETODOLAC at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency; VALACYCLOVIR [VALACICLOVIR] at an unspecified dose and frequency and MUPIROCIN at an unspecified dose and frequency. On 01-Apr-2021, HERPES ZOSTER (Shingles) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt a little tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa allergy) and Food allergy.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced FATIGUE (felt a little tired). At the time of the report, FATIGUE (felt a little tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-068488 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068488:Dose-2
Sex: U
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: big red rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (big red rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (big red rash). At the time of the report, RASH ERYTHEMATOUS (big red rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.    This case was linked to MOD21-069938, MOD21-069979 (E2B Linked Report).; Sender's Comments:  MOD21-069938:Crosslink MOD21-069979:Crosslink
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood count, Herpes zoster
Clinical narrative: shingles shoulder to breast (right side) , right dermatome; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles shoulder to breast (right side) , right dermatome) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included Shingles. Previously administered products included for Shingles: Zostavax (Patient received the first marketed Shingle vaccine years ago. LOT#044A21A).   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced HERPES ZOSTER (shingles shoulder to breast (right side) , right dermatome). The patient was treated with VALACICLOVIR at a dose of UNK UNK, bid. At the time of the report, HERPES ZOSTER (shingles shoulder to breast (right side) , right dermatome) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Blood count: shingles (Inconclusive) Blood work performed and diagnosis was "shingles"..         No relevant concomitant medications were reported.   This case was linked to MOD-2021-082095 (Patient Link).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dizziness, Palpitations
Clinical narrative: dizzy; a fast heartbeat, like their heart is pumping out of their chest; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and PALPITATIONS (a fast heartbeat, like their heart is pumping out of their chest) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 13-Feb-2021. Concurrent medical conditions included Blood pressure. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DIZZINESS (dizzy) and PALPITATIONS (a fast heartbeat, like their heart is pumping out of their chest). At the time of the report, DIZZINESS (dizzy) and PALPITATIONS (a fast heartbeat, like their heart is pumping out of their chest) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications provided were for high blood pressure. Treatment medication were not provided.